Unlike solid tumor cells where GZ17-6.02 as a single agent always was observed to cause significant amounts of ATM activation, this effect was not observed in MM cells, and unexpectedly, we found that bortezomib as a single agent activated ATM. The gene discussed is ATM; the disease is Miyoshi myopathy.